The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

Bone Marrow Transplant. 2023 Jul;58(7):826-828. doi: 10.1038/s41409-023-01975-9. Epub 2023 Apr 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myeloid*
  • Niacinamide
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles

Substances

  • asciminib
  • Pyrazoles
  • Niacinamide
  • Protein Kinase Inhibitors